Introduction

Olfaction is commonly viewed as a sensory system concerned with smell, memory and environmental recognition. However, the olfactory system is also anatomically connected to brain regions that regulate emotion, stress physiology, autonomic activity and endocrine responses.

Unlike most sensory pathways, olfactory signals reach the primary olfactory cortex and several limbic structures without first requiring a conventional thalamic relay. Odour information can therefore rapidly engage the amygdala, hippocampus, piriform cortex, orbitofrontal cortex, insula and hypothalamus—regions collectively involved in emotional salience, memory formation, threat detection, autonomic regulation and hypothalamic–pituitary–adrenal, or HPA, axis activity.

Through these neural networks, olfactory stimulation may indirectly influence immune function by modifying:

* sympathetic and parasympathetic tone,

* HPA-axis activation,

* glucocorticoid signalling,

* neuropeptide release,

* inflammatory cytokine production,

* microglial activity,

* sleep and circadian regulation,

* and behavioural stress responses.

This proposed olfactory–limbic–immune axis should not be interpreted as a single anatomical tract. It is better understood as an interconnected neuroimmune network through which odour perception, emotional processing, autonomic output and inflammatory biology interact.

1.Olfactory Signal Transduction: Converting Volatile Molecules into Neural Information

The process begins when volatile aromatic molecules dissolve within the mucus covering the olfactory epithelium. These molecules interact with olfactory receptors located on the cilia of olfactory sensory neurons.

Most olfactory receptors belong to the G-protein-coupled receptor superfamily. Ligand binding commonly activates the olfactory G protein, Golf, which stimulates adenylyl cyclase III and increases intracellular cyclic adenosine monophosphate, or cAMP.

The rise in cAMP opens cyclic nucleotide-gated ion channels, allowing sodium and calcium influx. Calcium subsequently activates chloride channels, amplifying membrane depolarisation and generating action potentials.

The signal is then transmitted through the axons of olfactory sensory neurons across the cribriform plate into the olfactory bulb. Neurons expressing the same receptor subtype converge within specialised structures called glomeruli, creating a spatially organised representation of odour identity.

Within the olfactory bulb, mitral and tufted cells process the signal through interactions with periglomerular and granule interneurons. These output neurons then project toward cortical and limbic structures.

Simplified molecular sequence

Volatile molecule → olfactory receptor → Golf activation → adenylyl cyclase III → cAMP elevation → cyclic nucleotide-gated channels → neuronal depolarisation → olfactory bulb

This receptor-level process explains how inhaled aromatic molecules can initiate rapid neural responses before considering any systemic pharmacological absorption.

2.Direct Access to Limbic and Emotional Circuits

Olfactory bulb output reaches several brain structures involved in emotional and physiological regulation, including:

* the piriform cortex,

* cortical and medial amygdala,

* entorhinal cortex,

* hippocampal networks,

* orbitofrontal cortex,

* insula,

* anterior cingulate cortex,

* and hypothalamus.

The amygdala assigns emotional and threat-related salience to sensory stimuli. The hippocampus integrates odours with memory and contextual information. The orbitofrontal cortex contributes to conscious odour identification, reward valuation and pleasantness. The insula participates in interoception, integrating sensory signals with the internal physiological state.

This arrangement explains why an odour can evoke a memory, emotional response or bodily sensation within seconds.

Importantly, the physiological response to an aroma is influenced not only by its molecular composition, but also by:

* previous associations,

* cultural conditioning,

* perceived safety,

* concentration,

* exposure duration,

* individual preference,

* sex,

* hormonal state,

* and the emotional context in which the odour is experienced.

Therefore, the same volatile stimulus may generate calming, neutral or aversive responses in different individuals.

Human research has demonstrated that pleasant odours activate networks involving the piriform cortex, amygdala, orbitofrontal cortex and insula. Acute psychological stress can also alter neural responsiveness to pleasant odours, indicating that olfaction and stress circuitry influence each other bidirectionally. 

3.Limbic Regulation of the HPA Axis

One of the major pathways through which olfactory and emotional processing may influence immunity is the HPA axis.

When the brain interprets a stimulus as threatening or stressful, the paraventricular nucleus of the hypothalamus releases corticotropin-releasing hormone, or CRH, and arginine vasopressin.

These hormones stimulate the anterior pituitary to release adrenocorticotropic hormone, or ACTH. ACTH then acts on the adrenal cortex, increasing cortisol production.

HPA-axis sequence

Perceived stimulus → limbic appraisal → hypothalamic CRH → pituitary ACTH → adrenal cortisol

The limbic system does not regulate this axis uniformly.

* The amygdala generally facilitates stress-related HPA activation.

* The hippocampus and portions of the medial prefrontal cortex generally participate in inhibitory feedback and contextual control.

* The hypothalamus integrates these signals and converts them into endocrine output.

The final cortisol response depends on the balance between excitatory and inhibitory limbic inputs. 

Cortisol and immunity

In an acute, appropriately regulated response, cortisol can limit excessive inflammation by:

* suppressing NF-κB-dependent transcription,

* reducing production of selected inflammatory cytokines,

* limiting immune-cell trafficking,

* modifying leukocyte metabolism,

* and promoting resolution of the stress response.

However, chronic or repetitive stress may produce a different biological pattern. Persistent HPA activation can contribute to:

* altered cortisol rhythms,

* impaired glucocorticoid-receptor sensitivity,

* reduced negative feedback,

* immune-cell glucocorticoid resistance,

* and continued inflammatory signalling despite elevated cortisol exposure.

Chronic stress may therefore produce the paradoxical combination of prolonged glucocorticoid activity and persistent low-grade inflammation.

Pro-inflammatory cytokines can, in turn, stimulate central stress pathways. This creates a reciprocal loop in which psychological stress alters immune signalling and immune mediators further influence the brain and HPA axis. 

Olfactory interventions that reduce perceived stress or modify limbic reactivity may therefore influence inflammatory biology indirectly by improving HPA-axis regulation. However, this mechanism remains more biologically plausible than clinically proven for most essential oils.

4.Autonomic Nervous System as a Neuroimmune Bridge

The autonomic nervous system provides a second major connection between olfactory processing and immunity.

Odour-related activity in the amygdala, insula, anterior cingulate cortex, hypothalamus and brainstem can influence sympathetic and parasympathetic output.

These responses may be reflected physiologically through changes in:

* heart rate,

* heart-rate variability,

* respiratory rate,

* blood pressure,

* pupil diameter,

* electrodermal activity,

* and peripheral vascular tone.

Human experiments indicate that odour exposure can acutely influence autonomic parameters. However, responses vary according to the specific odour, concentration, duration of exposure, sex and menstrual-cycle stage. 

Sympathetic–immune signalling

Sympathetic nerve terminals release noradrenaline, while the adrenal medulla releases adrenaline and noradrenaline into the circulation.

Immune cells express adrenergic receptors, particularly β2-adrenergic receptors. Adrenergic stimulation can alter:

* cytokine synthesis,

* leukocyte trafficking,

* antigen presentation,

* natural-killer-cell activity,

* lymphocyte proliferation,

* and macrophage function.

The effect is context dependent. Sympathetic activation is not uniformly inflammatory or anti-inflammatory. Its immune consequences depend on:

* receptor subtype,

* target tissue,

* neurotransmitter concentration,

* timing,

* disease stage,

* and duration of activation.

Short-term sympathetic activation may redistribute immune cells as part of an adaptive defence response. Persistent sympathetic dominance, however, may contribute to immune dysregulation, endothelial activation, altered antiviral responses and chronic inflammatory signalling.

Parasympathetic regulation

Parasympathetic activation, especially vagal signalling, is generally associated with anti-inflammatory effects.

The autonomic nervous system, HPA axis and immune system function as a coordinated, time-dependent stress-response network rather than as isolated systems. Parasympathetic effects are more consistently anti-inflammatory, whereas sympathetic effects are more variable and context specific. 

5.The Cholinergic Anti-inflammatory Pathway

The vagus nerve is one of the best-characterised neural regulators of inflammation.

Peripheral inflammatory mediators can activate vagal afferent fibres. These signals reach the nucleus tractus solitarius in the brainstem and are integrated with hypothalamic and autonomic circuits.

Descending vagal-related efferent signalling can then influence inflammatory activity through a neuroimmune reflex frequently called the inflammatory reflex or cholinergic anti-inflammatory pathway.

A simplified model involves:

1. detection of peripheral inflammatory signals,

2. vagal afferent transmission to the brainstem,

3. central integration,

4. descending autonomic output,

5. splenic sympathetic signalling,

6. acetylcholine release from specialised T lymphocytes,

7. activation of α7 nicotinic acetylcholine receptors on macrophages,

8. suppression of excessive inflammatory cytokine production.

Activation of α7 nicotinic receptors can reduce intracellular inflammatory signalling involving pathways such as:

* NF-κB,

* JAK2–STAT3,

* inflammasome activation,

* TNF-α production,

* IL-1β release,

* and IL-6 signalling.

The spleen is particularly important because direct vagal innervation of splenic immune cells is limited. Communication is mediated through a multisynaptic pathway involving the splenic nerve and acetylcholine-producing immune cells.

The relevance of this pathway to olfactory stimulation is indirect. An odour that reduces limbic threat processing, supports slower breathing or increases parasympathetic activity could theoretically enhance vagal regulatory tone. Nevertheless, a direct clinical demonstration that inhaled essential oils consistently activate the splenic cholinergic anti-inflammatory pathway in humans remains unavailable.

Thus, the correct scientific interpretation is:

Olfactory stimulation may influence autonomic state, and autonomic state can influence inflammation—but the complete causal sequence requires further clinical validation.

6.Neurogenic Inflammation and Sensory Chemoreceptors

Not all effects of inhaled aromatic molecules are mediated through classical olfactory receptors.

Volatile compounds may also activate chemosensory ion channels expressed on trigeminal nerve endings, respiratory epithelial cells and sensory neurons.

Important transient receptor potential channels include:

* TRPA1,

* TRPV1,

* TRPM8,

* and related sensory receptors.

For example:

* menthol activates TRPM8 and produces a cooling sensation,

* eucalyptol can influence TRP-channel signalling,

* cinnamaldehyde and allyl compounds may activate TRPA1,

* capsaicin-like irritants activate TRPV1.

Activation of trigeminal sensory pathways can influence:

* perceived nasal airflow,

* coughing,

* respiratory sensation,

* mucus secretion,

* vascular tone,

* neuropeptide release,

* and neurogenic inflammation.

Sensory neurons can release neuropeptides such as substance P and calcitonin gene-related peptide, or CGRP. These mediators may affect vascular permeability, mast-cell activity and local immune-cell recruitment.

Therefore, an inhaled aromatic compound may simultaneously generate:

1. an olfactory perception,

2. a trigeminal sensory response,

3. a local respiratory epithelial response,

4. and, after absorption, a systemic pharmacological response.

This distinction is essential because a perceived “opening” of the airways after menthol exposure may reflect altered sensory perception rather than measurable bronchodilation.

7.Neuroimmune Effects Within the Brain

Peripheral inflammation can communicate with the brain through:

* circulating cytokines,

* vagal afferents,

* endothelial signalling,

* circumventricular organs,

* immune-cell trafficking,

* and blood–brain barrier alterations.

Within the central nervous system, microglia function as resident innate immune cells. Activated microglia may release:

* TNF-α,

* IL-1β,

* IL-6,

* reactive oxygen species,

* nitric oxide,

* prostaglandins,

* and other inflammatory mediators.

These mediators can alter neuronal excitability, mood, cognition, sleep and pain processing.

Chronic psychological stress may also promote microglial priming and increase the sensitivity of neuroimmune circuits to subsequent inflammatory stimuli.

Because olfactory stimulation influences limbic and hypothalamic regions, stress-reducing odours may theoretically modify neuroimmune activity by lowering prolonged stress signalling. Some essential-oil constituents may additionally cross the blood–brain barrier and exert receptor-level or anti-inflammatory effects after pulmonary absorption.

However, it is important to separate three possible mechanisms:

1. Perceptual olfactory mechanism

The odour changes emotional appraisal, memory or perceived stress.

2. Neural autonomic mechanism

The odour alters sympathetic–parasympathetic balance or respiratory patterns.

3.Pharmacological mechanism

Volatile constituents enter the bloodstream and interact with molecular targets in the brain or peripheral tissues.

These mechanisms may occur simultaneously, but their relative contribution depends on the compound, dose, route and duration.

8.Direct Immunopharmacology of Essential-Oil Constituents

In addition to olfactory pathways, essential-oil constituents can enter the systemic circulation through the lungs and may directly interact with inflammatory pathways.

Preclinical studies suggest that selected essential oils or their constituents may influence:

* NF-κB signalling,

* mitogen-activated protein kinases,

* cyclooxygenase-2,

* lipoxygenase pathways,

* inducible nitric-oxide synthase,

* NLRP3 inflammasome activation,

* peroxisome proliferator-activated receptors,

* reactive oxygen species,

* and cytokine production.

Examples reported in experimental literature include:

* linalool and linalyl acetate, prominent in lavender,

* 1,8-cineole, prominent in eucalyptus,

* limonene, found in citrus oils,

* terpinen-4-ol, prominent in tea-tree oil,

* eugenol, found in clove oil,

* carvacrol and thymol, found in oregano and thyme,

* α-pinene, present in several conifer and resinous oils,

* and β-caryophyllene, a cannabinoid CB2-receptor agonist found in multiple aromatic plants.

A review of selected essential oils identified reductions in several inflammatory mediators and modulation of macrophage and lymphocyte responses. However, the authors also emphasised that clinical immunological data remain sparse and that safety and toxicological factors must be considered. 

A systematic review of experimental asthma models reported modulation of cytokines including TNF-α, IL-1β, IL-4, IL-5, IL-6, IL-13, IL-17, interferon-γ and IL-10. The included evidence was predominantly cellular and animal based, not definitive clinical evidence. 

In a murine asthma model, lavender essential-oil inhalation reduced allergic airway inflammation, mucous-cell hyperplasia and selected T-helper-2 cytokine responses. These findings demonstrate biological plausibility but cannot be directly extrapolated to routine human asthma management. 

Conclusion

The olfactory system is not merely a detector of fragrance. It is an entry point into neural circuits involved in emotion, memory, autonomic regulation, endocrine stress responses and inflammatory control.

Volatile aromatic molecules may influence physiology through several overlapping pathways:

1. activation of olfactory receptors,

2. engagement of limbic and hypothalamic networks,

3. modulation of the HPA axis,

4. alteration of sympathetic–parasympathetic balance,

5. interaction with the inflammatory reflex,

6. stimulation of trigeminal sensory channels,

7. and direct pharmacological action after systemic absorption.

Together, these interactions form a plausible olfactory–limbic–neuroimmune network.

Current evidence supports neurobiological plausibility and several short-term psychophysiological effects. Direct immunomodulatory findings are encouraging but remain predominantly preclinical. Well-designed human trials using chemically standardised oils, objective autonomic measurements, endocrine markers and validated immune endpoints are required before definitive therapeutic claims can be made.

Aromatherapy may not directly “boost immunity.” Its more scientifically defensible role may be to influence the regulatory systems through which the brain interprets stress and coordinates immune activity.

PubMed References

1. Mueller B, Figueroa A, Robinson-Papp J. Structural and functional connections between the autonomic nervous system, hypothalamic-pituitary-adrenal axis, and the immune system: a context- and time-dependent stress-response network. Neurol Sci. 2022;43(2):951–960. PMID: 35034231.

2. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(8):1201–1213. PMID: 16271821.

3. Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry. 2005;20 Suppl 3:S302–S306. PMID: 16459240.

4. Masuo Y, Satou T, Takemoto H, Koike K. Smell and stress response in the brain: review of the connection between chemistry and neuropharmacology. Molecules. 2021;26(9):2571. PMID: 33946804.

5. Fung TKH, Lau BWM, Ngai SPC, Tsang HWH. Therapeutic effect and mechanisms of essential oils in mood disorders: interaction between the nervous and respiratory systems. Int J Mol Sci. 2021;22(9):4844. PMID: 34063646.

6. Maharjan A, Ghista D, Maxwell RE, et al. Non-contact neuromodulation of the human autonomic nervous-system function via different odors: sex, menstrual-cycle and odor dose- and duration-specific effects. Front Neurosci. 2022;16:950282. PMID: 36312014.

7. Ai Y, Han P, Hummel T. Reduced neural responses to pleasant odor stimuli after acute psychological stress. Behav Brain Res. 2024;460:114799. PMID: 38008298.

8. Sandner G, Heckmann M, Weghuber J. Immunomodulatory activities of selected essential oils. Biomolecules. 2020;10(8):1139. PMID: 32756359.

9. Gurgel RQ, et al. Essential oils and their bioactive compounds modulating cytokines: a systematic review of anti-asthmatic and immunomodulatory properties. Phytomedicine. 2019;63:152854. PMID: 31036393.

10. Ueno-Iio T, Shibakura M, Yokota K, et al. Lavender essential-oil inhalation suppresses allergic airway inflammation and mucous-cell hyperplasia in a murine model of asthma. Life Sci. 2014;108(2):109–115. PMID: 24909715.

11. Zaccaro A, Piarulli A, Laurino M, et al. How breath control can change your life: a systematic review of psychophysiological correlates of slow breathing. Front Hum Neurosci. 2018;12:353. PMID: 30245619.

12. Nahm WJ, Falanga V, Kim KJ, Namgung E, Koo J. The role of the vagus nerve and its stimulation in modulating inflammatory skin diseases and other dermatologic conditions: from mechanisms to therapeutics. Dermatology. 2026. PMID: 42287674.